Trial Profile
A Multicenter, Randomized Controlled Trial of Cilostazol in Patients with Mild Cognitive Impairment
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Dec 2019
Price :
$35
*
At a glance
- Drugs Cilostazol (Primary)
- Indications Mild cognitive impairment
- Focus Therapeutic Use
- 03 Jun 2018 Status changed from recruiting to active, no longer recruiting.
- 17 May 2016 New trial record